KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles: 2011-2025

Historic Amortizatization of Intangibles for Acadia Pharmaceuticals (ACAD) over the last 15 years, with Sep 2025 value amounting to $2.7 million.

  • Acadia Pharmaceuticals' Amortizatization of Intangibles rose 16.17% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 11.92%. This contributed to the annual value of $15.0 million for FY2024, which is 98.63% up from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $2.7 million for Q3 2025, which was up 0.04% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Amortizatization of Intangibles registered a high of $5.3 million during Q1 2024, and its lowest value of -$689,000 during Q1 2021.
  • In the last 3 years, Acadia Pharmaceuticals' Amortizatization of Intangibles had a median value of $2.3 million in 2024 and averaged $2.8 million.
  • In the last 5 years, Acadia Pharmaceuticals' Amortizatization of Intangibles plummeted by 272.25% in 2021 and then surged by 1,591.00% in 2023.
  • Acadia Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at -$638,000 in 2021, then surged by 428.21% to $2.1 million in 2022, then fell by 15.04% to $1.8 million in 2023, then skyrocketed by 180.38% to $5.0 million in 2024, then increased by 16.17% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.7 million for Q2 2025, and $2.7 million during Q1 2025.